Breast Cancer
A PHASE II, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF NEOADJUVANT TREATMENT WITH INAVOLISIB COMBINATIONS IN PATIENTS WITH UNTREATED, EARLY-STAGE, PIK3CA-MUTATED BREAST CANCER
- Details
ClinicalTrials.gov ID:
NCT07054190
Diagnosis Type:
NA
USOR Number:
- Address
,
P: